Suscribirse

Home-based exercise program for people with residual disability following hospitalization for COVID-19: Randomized control trial - 27/03/24

Doi : 10.1016/j.rehab.2023.101815 
Mara Paneroni a, , Simonetta Scalvini b, Elisa Perger c, d, Elisabetta Zampogna e, Simone Govetto c, Federico Mattia Oliva e, Ambra Matrone b, Palmira Bernocchi b, Debora Rosa c, Michele Vitacca f
a Istituti Clinici Scientifici Maugeri IRCCS, Cardio-Respiratory Rehabilitation Unit of the Institute of Lumezzane, Brescia, Italy 
b Istituti Clinici Scientifici Maugeri IRCCS, Cardiac Rehabilitation and Continuity of Care Units of Institute of Lumezzane, Brescia, Italy 
c Istituto Auxologico Italiano, IRCCS, Sleep Disorders Center & Department of Cardiovascular, Neural and Metabolic Sciences, San Luca Hospital, Milan, Italy 
d University of Milano Bicocca, Department of Medicine and Surgery, Milan, Italy 
e Istituti Clinici Scientifici Maugeri IRCCS, Respiratory Rehabilitation Unit of the Institute of Tradate, Varese, Italy 
f Istituti Clinici Scientifici Maugeri IRCCS, Respiratory Rehabilitation Unit of the Institute of Lumezzane, Brescia, Italy 

Corresponding author at: Istituti Clinici Scientifici Maugeri IRCCS, Via G Mazzini,129, 25065 Lumezzane, Brescia, Italy.Istituti Clinici Scientifici Maugeri IRCCSVia G Mazzini,129LumezzaneBrescia25065Italy

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Highlights

For individuals with residual disability following COVID-19 a home-based exercise program can be feasible and safe.
A remotely-supported home-based exercise intervention is most effective for individuals in the worst physical condition.
An at-home exercise program should be a rehabilitative option for those recovering from COVID-19.

El texto completo de este artículo está disponible en PDF.

Abstract

Background

The best exercise program for individuals with effort intolerance or hypoxia at rest and/or during exercise post-COVID-19 treatment who have already had in-hospital rehabilitation remains unknown.

Objective

We evaluated the efficacy of a home-based rehabilitation exercise program intervention that included teleconsultations with a specialist nurse.

Methods

This was a multicenter randomized controlled trial for individuals who had been diagnosed with, and treated for, COVID-19. Despite inpatient rehabilitation they still had effort intolerance; this was defined as being a) only able to walk <70 % of the predicted distance during the six-minute walking test (6MWT) and/or b) oxygen desaturation all day long/during effort. The primary outcome was effort tolerance, as evaluated by the 6MWT. Secondary outcomes were dyspnea, fatigue, spirometry, respiratory muscle evaluations, and oxygenation. The Intervention group performed 4 weeks of a self-directed exercise program with bi-weekly physiotherapist video calls; the Control group participated in physical activity howsoever they wished. Exercises were divided into 4 intensity levels according to disability and oxygen desaturation. The program progressively increased from low (walking, free-body exercise, sit-to-stand, and balance exercises) to high (speed walking with a pedometer, cycle ergometer, and strengthening exercises).

Results

We included 79 participants: 40 in the Intervention and 39 in the Control group. Mean (SD) age was 67.1 (10.3) years; 72 % (n = 57) were male. No intergroup differences in effort tolerance were found [Intervention 77.6 (75.4)m vs Control 49.5 (73.3)m (p = 0.109)]. Participants with 6MWT distance results < lower limit of normality values showed best improvements in mean (SD) effort tolerance: Intervention, 120.1 (75.8)m vs Control, 59.1 (75.6)m (p = 0.035). After 2 months, mean (SD) 6MWT distances in the 2 groups were similar: Intervention, 475.9 (82.4)m vs Control, 469.2 (118.9)m (p = 0.807).

Conclusions

In individuals with residual disability post-COVID-19 and after inpatient rehabilitation, a home-based exercise program with teleconsultation significantly improves effort tolerance but only for people who had severe effort intolerance at baseline.

Database registration

ClinicalTrials.gov number, NCT04821934

El texto completo de este artículo está disponible en PDF.

Keywords : COVID-19, Exercise, Teleconsultation, Healthcare providers

Abbreviations : ATS, BMI, Borg CR10, CIRS, COPD, DLCO, EID, ERS, FSS, FiO2, FEV1, FVC, LLN, MCID, MEP, MIP, MCS, PCS, PCR, PaO2, PaCO2, PT, RCT, SF12, SPPB, 1MSTS, 6MWD, 6MWT


Esquema


© 2023  Elsevier Masson SAS. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 67 - N° 2

Artículo 101815- mars 2024 Regresar al número
Artículo precedente Artículo precedente
  • Editorial board
| Artículo siguiente Artículo siguiente
  • Beneficial carry-over effects of chronic at-home genital nerve stimulation on incontinence in individuals with spinal cord injury: A pragmatic trial
  • Shauh-Der Yeh, Nurida Khasanah, Kenneth J. Gustafson, Chi Sun, Mei-Lin Tsai, Bor-Shing Lin, Chun-Wei Wu, Chih-Wei Peng

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.